MTMaria Die Trill

Maria Die Trill

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Die Trill has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Psychosocial Interventions in Cancer Survivorship: A Rapid Scoping Review of the Recent PubMed-Indexed Literature

    by Anita Müller, Selma Barbot, Morgan Dondin, Clotilde Potez, Sylvie Dolbeault, Anne Brédart, Maria Die Trill, Bernhard Holzner

    Background/Objectives: In recent years, the number of cancer survivors has increased. Psychological difficulties or disorders are frequent during survivorship (e.g., fear of cancer recurrence, anxiety, depression, and insomnia). Various interventions have been developed to address survivors’ specific psychosocial needs. This rapid scoping review aimed to define the interventions that have been developed for adult cancer survivors by describing (1) the type of intervention, (2) their measured psychosocial outcome variables, and (3) participants’ main characteristics. Methods: PubMed was searched for articles published between 2020 and 2025. The search strategy combined terms related to cancer survivorship, psychosocial outcomes, and interventions. Titles and abstracts were screened, and data were extracted using a structured form specifying study type, population, intervention, and outcome characteristics. PRISMA-ScR guidelines were followed. Results: Out of 1743 screened studies, 80 were included (67 studies, 13 systematic reviews/meta-analyses), representing approximately 7880 cancer survivors (from the n = 67). Nearly 45% of included studies were conducted in the United States, and most interventions were developed for breast cancer survivors (38.8%) or included a majority of female participants. Physical activity (22.39%), psychoeducation (17.9%), and cognitive behavioural therapy (16.4%) were the most common intervention types. About a third incorporated eHealth or telehealth. Two-thirds of studies (65.7%) reported predominantly positive effects on psychosocial outcomes. Few interventions included cultural adaptations and targeted minority or socioeconomically disadvantaged populations. Conclusions: Most interventions for cancer survivors targeted breast cancer, female survivors in high-income countries. Developing and implementing culturally adapted and cost-efficient interventions, particularly for underrepresented survivor groups, remains a priority for future research and implementation.

  • Open Access

    Psychological aspects of depression in cancer patients: an update

    by M. Die Trill

    Depression and disorders of the depressive spectrum frequently remain underdiagnosed and undertreated in the cancer setting, despite their prevalence and the degree of suffering they impose on cancer patients. Initial shock, disbelief and denial are frequent upon confirmation of the cancer diagnosis. Generally, they begin to resolve within a few weeks as the patient receives support from family, friends and beliefs in addition to the support and outline provided by the medical oncologist, of a treatment plan that offers hope and reduces part of the uncertainty that is so difficult to deal with in oncology. However, multiple losses throughout the disease process, beginning with the loss of one's own health (followed by loss of body image, professional role, family roles, social roles, etc.) result in grief reactions and sadness that often accompany the cancer patient throughout the disease process. It is not uncommon, therefore, for depressed patients to feel depressed or sad at diagnosis, during treatment administration (due to toxicity, physical limitations, loss of body functions, changes in physical appearance, etc.); during remission and survival (e.g. due to fear of not receiving treatment that may keep the disease from reappearing, or due to inability to conduct life activities prior to diagnosis, among others); and during disease progression and palliative care (due to physical deterioration, confrontation with complex life and death issues, etc.). Depressive symptoms may, therefore, persist over time requiring specialized attention.